About Creyon Bio

Creyon Bio is reinventing drug development from the ground up and making on-demand oligonucleotide therapeutics possible. With powerful, purpose-built data sets to drive the efficient creation of machine learning models, we engineer oligonucleotide-based medicines (OBMs) for safe, precise gene-centric therapies with unprecedented speed and predictable efficacy and safety. It’s a groundbreaking modular approach that slashes costs for new medicines whether treating disease impacting one patient or millions.